FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4230738034> ?p ?o ?g. }

• W4230738034 endingPage "5062A" @default.
• W4230738034 startingPage "5062A" @default.
• W4230738034 abstract "Abstract Background: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in the US. It encompasses a range of conditions from hepatic steatosis to cirrhosis and liver cancer. Prior studies of the association between NAFLD and mortality have been limited by fairly short follow-up times, proxy measures of NAFLD and relatively few outcome events. Thus, the current study examined the association of NAFLD with all-cause and cause-specific mortality in the Third National Health and Nutrition Examination Survey (NHANES III) conducted in 1988-1994, with mortality follow-up through 2015. Methods: The analysis included 12605 individuals aged 20-74 years who underwent a hepatic/gallbladder ultrasound examination in NHANES III. NAFLD was defined as mild to severe hepatic steatosis detected by ultrasound in the absence of high alcohol consumption. Individuals were followed up for mortality by linkage to the National Death Index. Cox proportional hazard models were used to estimate the hazard ratios (HR) and 95% confidence intervals (CI) for all-cause and cause-specific mortality by NAFLD status as well as by a fibrosis score after adjustment for age, gender, race/ethnicity, education, physical activity, smoking, moderate alcohol consumption and body mass index. Results: The prevalence of NAFLD in the study was 33% and a total of 3,843 deaths occurred. More than 50% of the deaths were due to either cardiovascular disease (CVD) (34.2%) or cancer (18.7%). In addition, there were 83 (2.2%) deaths related to liver disease, including liver cancer. The risks of all-cause and cause-specific mortality were higher among persons with NAFLD than among persons without NAFLD: all-cause mortality [HR:1.22, 95%CI:1.10,1.36]; CVD [HR:1.12, 95%CI:0.96,1.31]; cancer [HR:1.34, 95%CI:1.04,1.72]; liver disease [HR:3.03, 95%CI:1.58,5.82]; kidney disease [HR:2.22, 95%CI:1.09,4.51]; diabetes [HR:2.55, 95%CI:1.48,4.39]. The risks of mortality from all-causes [HR:1.52, 95%CI:1.11,2.07], and from liver disease [HR:6.08, 95%CI:1.79,20.66] were markedly higher among persons with NAFLD with elevated liver enzymes than among persons without NAFLD. Among persons with NAFLD, a higher liver fibrosis score was significantly associated with increased risks of all-cause and liver disease mortality compared to those with lower fibrosis score: [HR:1.59, 95%CI:1.09,2.31] and [HR:17.08, 95%CI:4.08,71.56], respectively. Conclusions: Persons with NAFLD had an increased risk of all-cause and certain types of cause-specific mortality, independent of sociodemographic and lifestyle risk factors after 27 years of follow-up. Elevated liver enzymes as well as a higher fibrosis score among persons with NAFLD further increased the risk of all-cause and liver disease mortality. Persons with NAFLD should be closely monitored to prevent disease progression and reduce the risk of mortality in the US population. Citation Format: Christian S. Alvarez, Barry I. Graubard, Jake E. Thistle, Jessica L. Petrick, Katherine A. McGlynn. Non-alcoholic fatty liver disease and increased risk of mortality in NHANES III: Results after 27 years follow-up [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 5062A." @default.
• W4230738034 created "2022-05-11" @default.
• W4230738034 creator A5019312111 @default.
• W4230738034 creator A5034058169 @default.
• W4230738034 creator A5051247068 @default.
• W4230738034 creator A5062588511 @default.
• W4230738034 creator A5072801055 @default.
• W4230738034 date "2019-07-01" @default.
• W4230738034 modified "2023-09-27" @default.
• W4230738034 title "Abstract 5062A: Non-alcoholic fatty liver disease and increased risk of mortality in NHANES III: Results after 27 years follow-up" @default.
• W4230738034 doi "https://doi.org/10.1158/1538-7445.am2019-5062a" @default.
• W4230738034 hasPublicationYear "2019" @default.
• W4230738034 type Work @default.
• W4230738034 citedByCount "0" @default.
• W4230738034 crossrefType "journal-article" @default.
• W4230738034 hasAuthorship W4230738034A5019312111 @default.
• W4230738034 hasAuthorship W4230738034A5034058169 @default.
• W4230738034 hasAuthorship W4230738034A5051247068 @default.
• W4230738034 hasAuthorship W4230738034A5062588511 @default.
• W4230738034 hasAuthorship W4230738034A5072801055 @default.
• W4230738034 hasConcept C126322002 @default.
• W4230738034 hasConcept C207103383 @default.
• W4230738034 hasConcept C2776175330 @default.
• W4230738034 hasConcept C2777214474 @default.
• W4230738034 hasConcept C2777575235 @default.
• W4230738034 hasConcept C2778772119 @default.
• W4230738034 hasConcept C2779134260 @default.
• W4230738034 hasConcept C2779874844 @default.
• W4230738034 hasConcept C2780221984 @default.
• W4230738034 hasConcept C2908647359 @default.
• W4230738034 hasConcept C44249647 @default.
• W4230738034 hasConcept C50382708 @default.
• W4230738034 hasConcept C71924100 @default.
• W4230738034 hasConcept C90924648 @default.
• W4230738034 hasConcept C99454951 @default.
• W4230738034 hasConceptScore W4230738034C126322002 @default.
• W4230738034 hasConceptScore W4230738034C207103383 @default.
• W4230738034 hasConceptScore W4230738034C2776175330 @default.
• W4230738034 hasConceptScore W4230738034C2777214474 @default.
• W4230738034 hasConceptScore W4230738034C2777575235 @default.
• W4230738034 hasConceptScore W4230738034C2778772119 @default.
• W4230738034 hasConceptScore W4230738034C2779134260 @default.
• W4230738034 hasConceptScore W4230738034C2779874844 @default.
• W4230738034 hasConceptScore W4230738034C2780221984 @default.
• W4230738034 hasConceptScore W4230738034C2908647359 @default.
• W4230738034 hasConceptScore W4230738034C44249647 @default.
• W4230738034 hasConceptScore W4230738034C50382708 @default.
• W4230738034 hasConceptScore W4230738034C71924100 @default.
• W4230738034 hasConceptScore W4230738034C90924648 @default.
• W4230738034 hasConceptScore W4230738034C99454951 @default.
• W4230738034 hasIssue "13_Supplement" @default.
• W4230738034 hasLocation W42307380341 @default.
• W4230738034 hasOpenAccess W4230738034 @default.
• W4230738034 hasPrimaryLocation W42307380341 @default.
• W4230738034 hasRelatedWork W1997076034 @default.
• W4230738034 hasRelatedWork W2036534325 @default.
• W4230738034 hasRelatedWork W2411953491 @default.
• W4230738034 hasRelatedWork W2419247513 @default.
• W4230738034 hasRelatedWork W2977527746 @default.
• W4230738034 hasRelatedWork W3013910762 @default.
• W4230738034 hasRelatedWork W3125479117 @default.
• W4230738034 hasRelatedWork W3128654088 @default.
• W4230738034 hasRelatedWork W4226323221 @default.
• W4230738034 hasRelatedWork W4254036443 @default.
• W4230738034 hasVolume "79" @default.
• W4230738034 isParatext "false" @default.
• W4230738034 isRetracted "false" @default.
• W4230738034 workType "article" @default.